Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03621826 · ClinicalTrials.gov registry record
Evaluating Barriers to Stroke Screening and Prevention in Children With Sickle Cell Disease
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 5,247
- Enrollment target
NCT03621826: Completed study, sponsored by Medical University of South Carolina.
NCT03621826 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 5,247 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03621826 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 5,247 participants
- Enrollment target
Study Summary
DISPLACE is a three part, multi-center U.S. based study to evaluate the barriers to stroke screening and prevention in children with sickle cell anemia (SCA). In the United States, TCD (Transcranial Doppler ultrasound) is a proven method of screening children with SCA for stroke. However, many children are not getting the screening they need. This study will examine the issues that hinder and help children get the screening at 28 different hospitals and sickle cell centers to improve care for all children with sickle cell anemia. The investigators will then plan a study (part 3) aimed to improve stroke screening and prevention in sickle cell anemia.
Primary Outcome
Current rate of TCD screening over the last 5 years
Interventions
- OTHER Questionnaire/Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,247 participants |
| Start Date | 2018-02-12 |
| Est. Completion | 2019-06-28 |
What the finished NCT03621826 record still lists
NCT03621826 is an observational study that tracks outcomes without assigning an intervention. Its 5,247 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire/Interview is the first listed.
NCT03621826 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03621826 about?
NCT03621826 is a clinical study titled "Evaluating Barriers to Stroke Screening and Prevention in Children With Sickle Cell Disease". DISPLACE is a three part, multi-center U.S. based study to evaluate the barriers to stroke screening and prevention in children with sickle cell anemia (SCA). In the United States, TCD (Transcranial Doppler ultrasound) is a proven method of screening children with SCA for stroke. However, many child...
What is the current status of trial NCT03621826?
This trial is currently completed. The enrollment target is 5,247 participants. The study started on 2018-02-12. Estimated completion is 2019-06-28.
What interventions are being tested in trial NCT03621826?
The interventions under investigation include: Questionnaire/Interview (OTHER).
Who is sponsoring clinical trial NCT03621826?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06506344 · 5,250 participants · NA
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
- NCT05989308 · 5,200 participants · NA
MyChart Proxy Outreach to Parents (MyPOP)
- NCT06008197 · 5,200 participants · Phase 3
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- NCT05135403 · 5,179 participants
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI